4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-16-140757
EVP, QA & Regulatory Affairs sold 24,046 shares at $19.28 ($463,607)
- EVP, QA & Regulatory Affairs acquired 24,046 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-08-19 | Option exercise | +10,046 | $14.23 | $142,955 | 39,031 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-08-19 | Option exercise | +14,000 | $10.93 | $153,020 | 53,031 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-08-19 | Sale | −24,046 | $19.28 | $463,607 | 28,985 | D |
| Derivatives | |||||||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-08-19 | Option exercise · Employee Stock Option (right to buy) | −10,046 | 4,954 | D | ||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-08-19 | Option exercise · Employee Stock Option (right to buy) | −14,000 | 14,000 | D | ||
| Open-market sales · 24,046 sh · avg $19.28 · $463,607 | |||||||
Loading xslF345X03/a4.xml…